Genmab A/S
GMAB----
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Genmab A/S(GMAB) the Revenue is 1.145 B (+23.02%), Beat estimate;the EBIT is 371.89 M (+2.62%), Beat estimate;the EPS is 0.491 (-9.41%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.15B23.02%
1.11B18.74%
+0.04B4.28%
EBITExceed expectations
0.37B2.62%
0.34B5.10%
+0.03B7.72%
EPSExceed expectations
0.4919.41%
0.346336.11%
+0.144726.70%
Upcoming earnings report - 9 Months FY2026
Available dateNov 5, 2026
Estimate Revenue$1.191 B
Estimate EBIT--
Estimate EPS$0.3299
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf